FDA Investigator Susan M Miller
Susan M Miller has conducted inspections on 219 sites in 3 countries as of 11 Jul 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
219
Last Inspection Date:
11 Jul 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Italy,
Spain
FDA Investigators that have inspected at least one site in common with Susan M Miller:
Aaron L Dunbar,
Abraham M Maekele,
Adam J Taylor,
Alecia L Marson,
Alexander M Kay,
Allison E Sincek,
Amanda B Vega,
Amir Alavi,
Andrew Saunders,
Anthony L Nicoli,
Barbara A Gullick,
Barbara D Wright,
Boun M Xiong,
Brentley S Collins,
Brian L Szcyubialka,
Camilla S Smith,
Carolyn A Warren,
Catherine M Vanderhoef,
Chantel D Stennis,
Charles M Spyr,
Charles R Cote, RIC,
Christina A Castineyra,
Christine M Erickson,
Christopher C Wilcox,
Conor J Mccarron,
Corey K Reno,
Courtney R Ingalsbe,
Dale A Nyberg,
Darlene L Krieger,
Delkis J Caycedo,
Demetria L Lueneburg,
Denise L Burosh,
Dennis R Hudson,
Diane T Reindl,
Don A Leeseberg,
Donald R Goldsmith,
Donna D Gallien, MPH,
Elizabeth A Laudig,
Elizabeth B Griffin,
Elizabeth E Hart (ASCP), MT,
Elizabeth P Mayer,
Ellen C Weisensel,
Emily S Mcgann,
Emmanuel A Dimaano, Jr,
Eric A Breselow,
Eric T Huebler,
Esther A Ofori,
Fannie M Harrell,
Gail L Katz,
Garrett W Steiner,
George T Allen, Jr,
Gerald Mierle,
Gerald T O'connor,
Gina M Scholze,
Gloria A Milster,
Grant M Ruis,
Gregory S Larson,
Gregory W Smith,
Hoimay Chan,
Howard A Burmester,
Ivan E Reyes,
Jaclyn N Munsch,
Jacob W Reynolds,
Jacqueline M Bowling,
Jamie R Thompson,
Jane E Nelson,
Janis R Armedoriz,
Jasjeet K Sekhon,
Jean A Finger,
Jean M Bosenbecker,
Jeanne F Broderick,
Jeffery A Hangartner,
Jeffrey A Sincek,
Jeffry A Bernhardt,
Jennifer A Longie Vollom,
Jennifer Guttuso,
Jesse P Romenesko,
Jessica L Barr,
Joel D Hustedt,
John A Iwen,
John P Hermann,
Jon C Polzine,
Joseph D Gong,
Joseph M Edwin,
Joshua S Hoeh,
Joyce B Watson,
Justin A Boyd,
Justin J Jafferis,
Kaarin M Slotte,
Kailas Nagaraj,
Karen M Labounty,
Karla J Youngberg,
Katherine A Clarke Girolamo,
Kathleen B Swat,
Kellie L Thommes, RN,
Kellie L Westerbuhr,
Kenneth A Libertoski,
Kevin L Torgerson,
Kimberly W Destromp,
Kip J Hanks,
La Tasham Gunter,
Lauren M Lilly, PhD,
Laurie A Haxel,
LCDR Ismael Olvera, IV,
LCDR Matthew J Morrison,
Lee Terry Moore,
Leonard Pesetsky,
Lewis K Antwi,
Linda V Weyer,
Lisa M Lopez,
Lori A Holmquist,
Luis A Carrion,
Mada A Tautges,
Marc A Jackson, Jr,
Margaret A Foster,
Margaret Torres Vazquez,
Maria E Treadwell,
Maricelys Mercado,
Marlene L Davis,
Mary E Baker Brown,
Maryann Ruff,
Matthew J Gretkierewicz,
Melanie C Voges,
Melissa D Kalik,
Melissa J Holz,
Michael A Blaine,
Michael C Ireland,
Michael E Cimaglio,
Michelle J Glembin,
Minerva Rogers,
Mohammed H Adam,
Myra K Casey,
Nicholas J Dubrovin,
Nicholas S Vasilakes,
Nicole C Shokatz,
Normica G Facey,
Paola E Lathrop,
Patrick J Campbell,
Paul A Licata,
Peter R Lenahan,
Peter T Erlandson,
Rachel T Evans,
Rafael A Kaup,
Rebecca L Mullikin,
Richard W Koller,
Robert E Davis,
Robert J Waldorf,
Robert M Tillman,
Ronald R Ruff,
Rterry Bolen,
Sandra A Hughes,
Sandra Sejdinovic,
Sarah A Palmer,
Sarah L Clark,
Sarah Nwandiuko,
Scott B Laufenberg,
Scott L Schenian,
Scotty L Hargrave,
Stephanie Mangigian, MS/OSH, RN,
Susan M North,
Tania E Vizcaino,
Tanya L Keigley,
Tara M Carolfi,
Tara M Humfeld,
Terri L Jones,
Theresa C Klaman,
Thomas S Donaldson,
Thomas W Garvin,
Toni S Sturgis,
Traci C Kelm,
Travis S Bradley,
Tyson J Eldridge Stedman,
William E Keer,
William F Lagud, Jr,
William P Fournier,
Zoey A Trombley
Susan M Miller's Documents
Publish Date | Document Type | Title |
---|---|---|
December, 2014 | FDA 483 Response | American Tissue Services Foundation - Form 483R, 2014-12-29 |
December, 2014 | EIR | American Tissue Services Foundation - EIR, 2014-12-17 |
June, 2011 | FDA 483 | Innovative Blood Resources - Form 483, 2011-06-17 |
December, 2014 | FDA 483 | American Tissue Services Foundation - Form 483, 2014-12-17 |
April, 2010 | FDA 483 | American National Red Cross (The) - Form 483, 2010-04-23 |
February, 2013 | FDA 483 | CSL Plasma Inc. - Form 483, 2013-02-19 |
February, 2013 | FDA 483 Response | CSL Plasma Inc. - Form 483R, 2013-02-28 |
March, 2012 | FDA 483 | BloodCenter of Wisconsin Inc. Wisconsin Tissue Bank - Form 483, 2012-03-07 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more